Faiyaaz Kalimullah, MD
Dermatology · Chicago, ILNPI 1063729895
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $107,258 of the $137,120 with a category attached, or 78.2%. AbbVie accounts for 83.1% of it on its own, with 29 other manufacturers making up the rest. Reporting peaked in 2021 at $38,078 and has fallen 81.2% since, to $7,157 in 2025. Among dermatology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 819 payments — averaging $167.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$114K
- Galderma Laboratories, L.p.$14K
- Johnson & Johnson$1K
- Pfizer$1K
- Regeneron Healthcare Solutions, Inc.$980
- Amgen$823
- plus $5K from 24 others
What the payments were for
- Consulting fees$7,8006%
- Speaking & faculty fees$107,25878%
- Travel & lodging$3,7093%
- Food & beverage$18,04113%
- Education$3120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 293 | $113,959 |
| Galderma Laboratories, L.p. | 80 | $13,874 |
| Johnson & Johnson | 84 | $1,443 |
| Pfizer | 37 | $1,004 |
| Regeneron Healthcare Solutions, Inc. | 40 | $980 |
| Amgen | 37 | $823 |
| Lilly USA, LLC | 37 | $751 |
| Revance Therapeutics, Inc. | 4 | $481 |
| Dermavant Sciences, Inc. | 36 | $439 |
| Sun Pharmaceutical Industries Inc. | 15 | $377 |
| Mayne Pharma Commercial LLC | 24 | $349 |
| VYNE Pharmaceuticals Inc. | 11 | $338 |
| Dermira, Inc. | 25 | $263 |
| Novartis | 13 | $259 |
| Sanofi | 10 | $250 |
| Arcutis Biotherapeutics, Inc. | 12 | $229 |
| Incyte Corporation | 10 | $227 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 12 | $192 |
| LEO Pharma Inc. | 9 | $189 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $140 |
| UCB, Inc. | 6 | $114 |
| Boehringer Ingelheim | 5 | $114 |
| Journey Medical Corporation | 5 | $110 |
| Aclaris Therapeutics, Inc. | 2 | $39 |
| Bristol Myers Squibb | 2 | $36 |
| Almirall LLC | 2 | $32 |
| Mission Pharmacal Company | 2 | $31 |
| EPI Health, LLC | 2 | $31 |
| Merz North America, Inc. | 1 | $29 |
| Organon | 2 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$137,120 in reported general payments places this provider in the 95th percentile of 606 dermatology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Chicago
- Raj ChovatiyaChicago$3.6M
- Peter LioChicago$2.4M
- Elizabeth KiracofeChicago$1.6M
- Carolyn JacobChicago$566K
- Walter LiszewskiChicago$414K
- Omer IbrahimChicago$313K
- Caroline RobinsonChicago$308K
- Smita AggarwalChicago$214K
- Tracee BlackburnChicago$180K
- Sarah ChamlinChicago$135K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.